Collegium Pharmaceutical, Inc. Depreciation and Amortization
Collegium Pharmaceutical, Inc. (COLL) reported Depreciation and Amortization of $589.00 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2020-11-05
- Collegium Pharmaceutical, Inc. depreciation, depletion and amortization for the quarter ending 2020-09-30 was $195.00K, a 8.33% increase year-over-year.
- Collegium Pharmaceutical, Inc. depreciation, depletion and amortization for the quarter ending 2020-06-30 was $196.00K, a 14.62% increase year-over-year.
- Collegium Pharmaceutical, Inc. depreciation, depletion and amortization for the quarter ending 2020-03-31 was $198.00K, a 7.61% increase year-over-year.
- Collegium Pharmaceutical, Inc. depreciation, depletion and amortization for the quarter ending 2019-12-31 was $196.00K, a 42.69% decline year-over-year.
- Collegium Pharmaceutical, Inc. depreciation, depletion and amortization for fiscal 2019 was $731.00K, a 31.94% decline from fiscal 2018.
- Collegium Pharmaceutical, Inc. depreciation, depletion and amortization for fiscal 2018 was $1.07M, a 80.81% increase from fiscal 2017.
- Collegium Pharmaceutical, Inc. depreciation, depletion and amortization for fiscal 2017 was $594.00K, a 9.31% decline from fiscal 2016.
- Collegium Pharmaceutical, Inc. depreciation, depletion and amortization for fiscal 2016 was $655.00K, a 283.04% increase from fiscal 2015.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|---|---|
| 2020-09-30 | $195.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $391.00K derived: sum of 2 quarters · filed 2020-11-05 | $589.00K 10-Q · filed 2020-11-05 | $785.00K derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | $196.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $394.00K 10-Q · filed 2020-08-05 | $590.00K derived: sum of 3 quarters · filed 2020-08-05 | $770.00K derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-03-31 | $198.00K 10-Q · filed 2020-05-07 | $394.00K derived: sum of 2 quarters · filed 2020-05-07 | $574.00K derived: sum of 3 quarters · filed 2020-11-05 | $745.00K derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-12-31 | $196.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $376.00K derived: sum of 2 quarters · filed 2020-11-05 | $547.00K derived: sum of 3 quarters · filed 2020-11-05 | $731.00K 10-K · filed 2020-02-27 |
| 2019-09-30 | $180.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $351.00K derived: sum of 2 quarters · filed 2020-11-05 | $535.00K 10-Q · filed 2020-11-05 | $877.00K derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $355.00K 10-Q · filed 2020-08-05 | $697.00K derived: sum of 3 quarters · filed 2020-08-05 | $851.00K derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $184.00K 10-Q · filed 2020-05-07 | $526.00K derived: sum of 2 quarters · filed 2020-05-07 | $680.00K derived: sum of 3 quarters · filed 2020-05-07 | $776.00K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $342.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $496.00K derived: sum of 2 quarters · filed 2020-02-27 | $592.00K derived: sum of 3 quarters · filed 2020-02-27 | $1.07M 10-K · filed 2020-02-27 |
| 2018-09-30 | $154.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $250.00K derived: sum of 2 quarters · filed 2019-11-06 | $732.00K 10-Q · filed 2019-11-06 | $862.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $96.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $578.00K 10-Q · filed 2019-08-07 | $708.00K derived: sum of 3 quarters · filed 2020-02-27 | $840.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $482.00K 10-Q · filed 2019-05-08 | $612.00K derived: sum of 2 quarters · filed 2020-02-27 | $744.00K derived: sum of 3 quarters · filed 2020-02-27 | $868.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $262.00K derived: sum of 2 quarters · filed 2020-02-27 | $386.00K derived: sum of 3 quarters · filed 2020-02-27 | $594.00K 10-K · filed 2020-02-27 |
| 2017-09-30 | $132.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $256.00K derived: sum of 2 quarters · filed 2017-11-08 | $464.00K 10-Q · filed 2017-11-08 | $759.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $124.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $332.00K 10-Q · filed 2017-08-09 | $627.00K derived: sum of 3 quarters · filed 2019-02-27 | $900.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $208.00K 10-Q · filed 2017-05-10 | $503.00K derived: sum of 2 quarters · filed 2019-02-27 | $776.00K derived: sum of 3 quarters · filed 2019-02-27 | $820.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $295.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $568.00K derived: sum of 2 quarters · filed 2019-02-27 | $612.00K derived: sum of 3 quarters · filed 2019-02-27 | $655.00K 10-K · filed 2019-02-27 |
| 2016-09-30 | $273.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $317.00K derived: sum of 2 quarters · filed 2017-11-08 | $360.00K 10-Q · filed 2017-11-08 | $401.00K derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | $44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $87.00K 10-Q · filed 2017-08-09 | $128.00K derived: sum of 3 quarters · filed 2018-03-07 | $166.00K derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | $43.00K 10-Q · filed 2017-05-10 | $84.00K derived: sum of 2 quarters · filed 2018-03-07 | $122.00K derived: sum of 3 quarters · filed 2018-03-07 | $168.00K derived: sum of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $79.00K derived: sum of 2 quarters · filed 2018-03-07 | $125.00K derived: sum of 3 quarters · filed 2018-03-07 | $171.00K 10-K · filed 2018-03-07 |
| 2015-09-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $84.00K derived: sum of 2 quarters · filed 2016-11-10 | $130.00K 10-Q · filed 2016-11-10 | |
| 2015-06-30 | $46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $92.00K 10-Q · filed 2016-08-11 | ||
| 2015-03-31 | $46.00K 10-Q · filed 2016-05-11 | |||
| 2014-12-31 | $187.00K 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |